Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Popovic

Showing results (71-80 of 303) with videos related to

Pageof 31
Sort By:
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 5, 2008
Cardiac output following fetoscopic coagulation of major placental vessels in fetal sheepM Tchirikov, M Strohner, S Popovic, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 16, 2024
Sodium-Glucose Co-transporter-2 Inhibitors in Type 1 Diabetes Mellitus: The Framework for Recommendations for Their Potential UseDjordje S Popovic, Dimitrios Patoulias, Theocharis Koufakis, et al.
World Journal of Diabetes|May 20, 2024
Drawing lines in the sand: The growing threat of obesity in type 1 diabetesTheocharis Koufakis, Dimitrios Patoulias, Ioanna Zografou, et al.
Diabetes, Obesity & Metabolism|March 8, 2024
Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetesDjordje S Popovic, Dimitrios Patoulias, Paschalis Karakasis, et al.
Expert Opinion on Pharmacotherapy|January 29, 2024
Effectively addressing cardiovascular risk in people with metabolic-dysfunction associated fatty liver disease: not yet ready for prime time!Theocharis Koufakis, Djordje S Popovic, Christodoulos Papadopoulos, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 28, 2025
The Therapeutic Potential of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Peripheral NeuropathyTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Expert Review of Clinical Pharmacology|September 9, 2025
Dual incretin agonism and the gut microbiome: does the heart of metabolic regulation beat in the gut?Theocharis Koufakis, Dimitrios Patoulias, Maria Apostolopoulou, et al.
European Journal of Internal Medicine|December 3, 2025
Tirzepatide as adjunct to insulin for the treatment of type 1 diabetesDimitrios Patoulias, Eleftherios Teperikidis, Djordje S Popovic, et al.
Expert Opinion on Drug Safety|October 11, 2022
Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attentionDjordje S Popovic, Theocharis Koufakis, Bojan Kovacevic, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 24, 2024
Intentional Insulin Overdose and Depression in Subjects with and Without Diabetes Mellitus: A CommentaryEvanthia Gouveri, Aikaterini Gkouveri, Djordje S Popovic, et al.
Pageof 31

Showing results (71-80 of 303) with videos related to

Sort By:
Pageof 31
Ultrasound in Obstetrics & Gynecology : the Official Journal of the International Society of Ultrasound in Obstetrics and Gynecology|August 5, 2008
Cardiac output following fetoscopic coagulation of major placental vessels in fetal sheepM Tchirikov, M Strohner, S Popovic, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|October 16, 2024
Sodium-Glucose Co-transporter-2 Inhibitors in Type 1 Diabetes Mellitus: The Framework for Recommendations for Their Potential UseDjordje S Popovic, Dimitrios Patoulias, Theocharis Koufakis, et al.
World Journal of Diabetes|May 20, 2024
Drawing lines in the sand: The growing threat of obesity in type 1 diabetesTheocharis Koufakis, Dimitrios Patoulias, Ioanna Zografou, et al.
Diabetes, Obesity & Metabolism|March 8, 2024
Effect of tirzepatide on the risk of diabetic retinopathy in type 2 diabetesDjordje S Popovic, Dimitrios Patoulias, Paschalis Karakasis, et al.
Expert Opinion on Pharmacotherapy|January 29, 2024
Effectively addressing cardiovascular risk in people with metabolic-dysfunction associated fatty liver disease: not yet ready for prime time!Theocharis Koufakis, Djordje S Popovic, Christodoulos Papadopoulos, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|March 28, 2025
The Therapeutic Potential of Dipeptidyl Peptidase 4 Inhibitors and Glucagon-Like Peptide-1 Receptor Agonists in Diabetic Peripheral NeuropathyTheodoros Panou, Evanthia Gouveri, Djordje S Popovic, et al.
Expert Review of Clinical Pharmacology|September 9, 2025
Dual incretin agonism and the gut microbiome: does the heart of metabolic regulation beat in the gut?Theocharis Koufakis, Dimitrios Patoulias, Maria Apostolopoulou, et al.
European Journal of Internal Medicine|December 3, 2025
Tirzepatide as adjunct to insulin for the treatment of type 1 diabetesDimitrios Patoulias, Eleftherios Teperikidis, Djordje S Popovic, et al.
Expert Opinion on Drug Safety|October 11, 2022
Immune checkpoint inhibitors-induced diabetes mellitus: a growing clinical presentation requiring our attentionDjordje S Popovic, Theocharis Koufakis, Bojan Kovacevic, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|July 24, 2024
Intentional Insulin Overdose and Depression in Subjects with and Without Diabetes Mellitus: A CommentaryEvanthia Gouveri, Aikaterini Gkouveri, Djordje S Popovic, et al.
Pageof 31